This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study
- PET Approaches for Diagnosis of Dementia
- Potential for misdiagnosis in community-acquired PET scans for dementia
- The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
- Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
- Teaching NeuroImages: Apathetic variant of frontotemporal dementia
- Effect of Prefiltering Cutoff Frequency and Scatter and Attenuation Corrections During Normal Database Creation for Statistical Imaging Analysis of the Brain
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
- Positron emission tomography imaging in dementia
- What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
- Imaging in dementia
- 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
- Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.
- Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease
- 18F-FDG PET Findings in Frontotemporal Dementia: An SPM Analysis of 29 Patients
- Brain 18F-FDG PET in the Diagnosis of Neurodegenerative Dementias: Comparison with Perfusion SPECT and with Clinical Evaluations Lacking Nuclear Imaging
- Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD
- Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia
- Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology